Dr. Kunal D

First one is on our reported growth of arou nd 22% for the domestic prescription business. If I strip out our consumer business and we have mentioned categorically two things, modern trade and hospital sales. So, just like to know are those a big growth factor in this quarter? And if yes, can you quantify those?

Just one bit on the sequential compression in the gross margin. Is it primarily on the back of more, I mean , acute kind of also recovering from Q2 to Q3 , and maybe some of these newer businesses might have some lower gross margin, is that the correct way to understand?

And it should come back barring the product mix changes, etc., we expect this to reverse, right?